Psychotropic
pharmaceuticalsand their metabolites are
a growing
concern for aquatic environments and may accumulate in aquatic organisms.
In this study, 21 parent psychotropic pharmaceuticals and 8 metabolites
from three categories of psychotropic drugs (anxiolytics, antiepileptics,
and antidepressants) were evaluated in Gao–Bao–Shaobo
lake (GBSL), a shallow lake in China. Among them, 18 psychotropic
pharmaceuticals and 8 metabolites were detected in water samples from
GBSL (0.2 up to ∼24.5 ng/L), and 13 psychotropic pharmaceuticals
and 5 metabolites were identified in fish (1 up to ∼126.2 ng/g
dw). In the wet season, concentrations of psychotropic pharmaceuticals
and their metabolites showed an increase from the inflow to the discharge
subarea. Carbamazepine and sertraline were the dominant pharmaceuticals
detected in fish with bioaccumulation factors, exceeding 5000 L/kg.
Physicochemical parameters (log K
ow and
MW) were negatively correlated with the pharmaceutical levels in fish.
Carbamazepine posed a moderate risk to aquatic organisms in all subareas.
Hazard quotient results showed that the consumption of fish from GBSL
is unlikely to exhibit a direct adverse effect on humans. Our results
indicated that a comprehensive understanding of psychotropic pharmaceutical
contaminations in surface waters should consider not only the parent
pharmaceuticals but also the subsequent accumulation of their metabolites
in fish.